Your browser doesn't support javascript.
loading
Cyclodextrine screening for the chiral separation of carvedilol by capillary electrophoresis
IJPR-Iranian Journal of Pharmaceutical Research. 2015; 14 (2): 425-433
in English | IMEMR | ID: emr-167947
ABSTRACT
Carvedilol is administered as a racemic mixture of the R[+]- and S[-]-enantiomers, although it was demonstrated that the two enantiomers exhibit different pharmacological effects and stereoselective pharmacokinetics. The aim of this study was the evaluation of several native and derivatized cyclodextrines as chiral selectors for the separation of carvedilol enantiomers. Stereoselective interactions were observed with four cyclodextrines [beta-CD, hydroxypropyl-beta-CD, randomly methylated beta-CD and sulfobuthyl ether-beta-CD]. The effects of CD concentration, pH value and composition of the background electrolyte, capillary temperature, running voltage and injection parameters have been investigated. The method was validated for precision of peak-area response, linearity range and limits of detection and quantification. An efficient stereoselective capillary zone electrophoretic method was developed for the determination of carvedilol enantiomers using a simple 25 mM phosphate buffer at a pH = 2.5 and 10 mM beta-CD as chiral selector, resulting in baseline separation of the two enantiomers with sharp peaks and relatively short analysis time. Highly satisfactory results were obtained from the analysis of carvedilol from tablets, indicating that the method is suitable for routine analysis of carvedilol in pharmaceutical products
Subject(s)
Search on Google
Index: IMEMR (Eastern Mediterranean) Main subject: Propanolamines / Electrophoresis, Capillary / Cyclodextrins Type of study: Screening study Language: English Journal: Iran. J. Pharm. Res. Year: 2015

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Index: IMEMR (Eastern Mediterranean) Main subject: Propanolamines / Electrophoresis, Capillary / Cyclodextrins Type of study: Screening study Language: English Journal: Iran. J. Pharm. Res. Year: 2015